Skip to content
Screener

CG Oncology CGON Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$40.77M+0.5%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$16.99M-7.9%
UroGen Pharma logo
UroGen PharmaURGN
$3.04M+150%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.8M+115%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Replimune Group logo
Replimune GroupREPL
$3.73M-15.1%

Other financials

Income statement

See full
Revenue$1.2M—
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total debt$8.8M+787%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.6B+242%
Enterprise value$6.59B+244%
P/S1,060×-2,439×

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp
FCF margin-2,879.6%-1,307pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0×0.0×
Current ratio22.2×+0.1×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918
20271,434
20281,470
20291,403
20301,329
Thereafter562
Total lease payment6,862
Less: amount representing imputed interest(1,043)
Total future minimum lease obligations$5,819

Item 1. Financial Statements.

FAQ

What is CG Oncology's operating lease liabilities (total)?
CG Oncology (CGON) reported operating lease liabilities (total) of $5.82M in Q2 2026.
How has CG Oncology's operating lease liabilities (total) changed year-over-year?
CG Oncology's operating lease liabilities (total) increased by 485.4% year-over-year, from $994K to $5.82M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about CG Oncology's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude